Guilherme Maradei, managing director of Merck Brazil and general manager Biopharma, documents the eye-catching growth that the Brazilian affiliate has been experiencing over the past two years and provides insights into the outstanding footprint of the company in Brazil as well as its remarkable ambitions and achievements when it comes to innovative partnerships with both public and private stakeholders.
Looking at your career path, you worked for almost seven years at McKinsey in Brazil and the US before taking over strategic positions at regional and global levels at Pfizer for around six years. What motivated you to look for country manager positions in Brazil, first at Valeant and now at Merck?
"Like a few other emerging markets, Brazil is very large and diverse, but also extremely complex and volatile, which means that the dynamics in the private and public markets can change abruptly."
